Julia Heather Entis, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 11928 Beach Club Way, Malibu, CA 90265 Phone: 310-923-1632 |
Erica I Reynoso, PH.D. , LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 427 Encinal Canyon Rd, Malibu, CA 90265 Phone: 818-735-2805 |
Mr. Seth Mcrae Amitin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 28955 Pacific Coast Hwy, Malibu, CA 90265 Phone: 818-692-9682 |
Mr. Jose Ricardo Mottos, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 427 Encinal Canyon Rd, Malibu, CA 90265 Phone: 818-735-2805 |
Julie Lynn Martucci, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11946 Oceanaire Ln, Malibu, CA 90265 Phone: 614-325-4749 |
Samantha Blaustein, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24903 Pacific Coast Hwy, Malibu, CA 90265 Phone: 310-310-9249 |
Jacque Monaghan Barberie, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 31727 Mulholland Hwy, Malibu, CA 90265 Phone: 818-631-5236 |
Mr. Dimitri Vitebsky, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 427 Encinal Canyon Rd, Malibu, CA 90265 Phone: 213-266-2857 |
Mrs. Kristy Lynn Hamilton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24521 Mariposa Cir, Malibu, CA 90265 Phone: 719-360-7567 |
News Archive
Data presented today on Medtronic's Solitaire stent retriever at the International Stroke Conference in Houston demonstrate that the results from the four pivotal randomized controlled trials – SOLITAIRE FR With the Intention For Thrombectomy as PRIMary Endovascular Treatment for Acute Ischemic Stroke, Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke, EXtending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial and Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours – can be replicated in U.S. centers, in a pragmatic, real-world setting reconfirming the benefits of mechanical thrombectomy in patients suffering acute ischemic stroke (AIS).
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
› Verified 7 days ago